|
Volumn 147, Issue 9, 2007, Pages 603-610
|
Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: A randomized trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
ESCHERICHIA COLI NISSLE 1917 EXTRACT;
EUDRAGIT;
MERCAPTOPURINE;
MESALAZINE;
PHOSPHATIDYLCHOLINE;
PLACEBO;
PREDNISOLONE;
PREDNISONE;
PROBIOTIC AGENT;
STEROID;
CORTICOSTEROID;
ADULT;
ARTICLE;
BLOATING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG WITHDRAWAL;
ENDOSCOPY;
FEMALE;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
STEROID THERAPY;
ULCERATIVE COLITIS;
DELAYED RELEASE FORMULATION;
GASTROINTESTINAL ENDOSCOPY;
INTESTINE MUCOSA;
METABOLISM;
MUCUS;
PATHOLOGY;
SAMPLE SIZE;
TREATMENT OUTCOME;
ADRENAL CORTEX HORMONES;
ADULT;
COLITIS, ULCERATIVE;
DELAYED-ACTION PREPARATIONS;
DOUBLE-BLIND METHOD;
ENDOSCOPY, GASTROINTESTINAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTESTINAL MUCOSA;
MALE;
MUCUS;
PHOSPHATIDYLCHOLINES;
QUALITY OF LIFE;
SAMPLE SIZE;
TREATMENT OUTCOME;
|
EID: 38449107095
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-147-9-200711060-00004 Document Type: Article |
Times cited : (87)
|
References (21)
|